Emerging medications for ADHD are slowly coming to the market for physicians to use. They tend to be more long‑acting and cover 12 to 16 hours. Many times today with kids homework/sports a longer formulations is needed. The agents below modulate norepinephrine amongst other hormones. An agent that has been used for some time is Straterra which works similarly.
Women appeared to have a greater lifetime risk for obsessive-compulsive disorder than men, according to results of a meta-analysis published in Journal of Clinical Psychiatry. Traditionally OCD has been considered to be an illness in 3 to 5 percent of the population. For many years we have believed as psychiatrists that there is no gender differential between ment and women.
Children with sensory processing disorder (SPD) may feel things intensely — or not at all. They may be hypersensitive to noise, fluorescent lighting, cafeteria smells, and new movement. Or they may feel their senses are muted and physically seek out stimulation — playing rough, bouncing boundlessly, or touching everything and everyone all the time.
There has been concerns in the medical community and lay community at large that Covid 19 on College Campuses is growing exponentially. It is a hazard to the adults especially the elderly. There is a concern that young adults have not quite grasped the significant and serious hazards of the condition. Child psychiatrists and adult psychiatrists alike feel that college is a transitional age with young people at varying maturity.
In order to slow the spread of the novel coronavirus, we have made several life-impacting changes. Most Americans are staying at home aside from going out for essentials and emergencies. Schools have closed and shifted to online versions. Many employees are working from home. People are encouraged to maintain six feet between each other for social distancing.
Attention Deficit Hyperactivity Disorder (ADHD) is one of the most common neurodevelopmental disorders diagnosed in children. The CDC estimates that over 6 million children have been diagnosed with ADHD, which translates into about 9.4% of children aged 4-17.
Have you been considering having your child tested for Attention Deficit Hyperactivity Disorder (ADHD)? Perhaps you’ve noticed behaviors that your child has that are different from his or her peers. Or maybe your child’s teacher has reported his behaviors are preventing him from doing as well as he could in his schoolwork.
Children with Attention Deficit Hyperactivity Disorder (ADHD) often have a constellation of symptoms including inattention, impulsivity, difficulty focusing, and hyperactivity. For many children, there is another symptom that is often overlooked: managing emotions. Despite its prevalence among children and teens with ADHD, it is not one of the diagnostic criteria of ADHD.
Children with anxiety may redo assignments that weren't done perfectly. spend an excessive amount of time on homework. worry about sports performance or appear to be a perfectionist.
There is a new medication to treat Attention Deficit Hyperactivity Disorder (ADHD) available through your child and adolescent psychiatrist. Jornay PM is a stimulant used to treat ADHD symptoms in children six years and older. Jornay PM is a methylphenidate-based medication, but it has a special feature. Taken at night, Jornay PM has been shown to control ADHD symptoms from the time the child wakes up in the morning and keeps working right through the day.
